Neurotrope: Saving synapses

Neurotrope targets PKC deficits as underlying cause of Alzheimer's

Neurotrope BioScience Inc. is developing Alzheimer's disease therapeutics targeting protein kinase C, an enzyme that could play a central role in pathology upstream of amyloid plaques and neurofibrillary tangles. The potential mechanism could explain the limited success of amyloid-targeted therapies.

Most companies pursuing AD develop therapeutics to prevent or remove the amyloid plaques or neurofibrillary tangles found in AD brains. Yet these plaques and tangles do not correlate with degree of dementia during life, and antibody therapies that reduced plaques did not improve dementia.

Autopsy studies

Read the full 848 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE